C. Cardwell

First name
C.
Middle name
R.
Last name
Cardwell
Murphy, J. D., Gadalla, S. M., Anderson, L. A., Rabkin, C. S., Cardwell, C. R., Song, M., & Camargo, M. C. (2024). Autoimmune conditions and gastric cancer risk in a population-based study in the United Kingdom. Br J Cancer. http://doi.org/10.1038/s41416-024-02714-7
View
Cardwell, C. R., McDowell, R. D., Hughes, C. M., Busby, J., & Murchie, P. (2024). Oral prednisolone and warfarin and risk of oesophageal cancer: A case-control study. Cancer Epidemiol, 90, 102552. http://doi.org/10.1016/j.canep.2024.102552
View
Doherty, N., Cardwell, C. R., Murchie, P., Hill, C., Azoulay, L., & Hicks, B. (2023). 5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Cancer Epidemiol Biomarkers Prev. http://doi.org/10.1158/1055-9965.epi-22-1109
View
Cardwell, C. R., Carson, D. J., & Patterson, C. C. (2008). No association between routinely recorded infections in early life and subsequent risk of childhood-onset Type 1 diabetes: a matched case-control study using the UK General Practice Research Database. Diabet Med. http://doi.org/10.1111/j.1464-5491.2007.02351.x
View
Cardwell, C. R., McKinney, P. A., Patterson, C. C., & Murray, L. J. (2008). Infections in early life and childhood leukaemia risk: a UK case-control study of general practitioner records. Br J Cancer. http://doi.org/10.1038/sj.bjc.6604696
View
Cardwell, C. R., Abnet, C. C., Cantwell, M. M., & Murray, L. J. (2010). Exposure to oral bisphosphonates and risk of esophageal cancer. Jama. http://doi.org/10.1001/jama.2010.1098
View
Cardwell, C. R., Abnet, C. C., Veal, P., Hughes, C. M., Cantwell, M. M., & Murray, L. J. (2012). Exposure to oral bisphosphonates and risk of cancer. Int J Cancer. http://doi.org/10.1002/ijc.27389
View
Bannon, F. J., O\textquoterightRorke, M. A., Murray, L. J., Hughes, C. M., Gavin, A. T., Fleming, S. J., & Cardwell, C. R. (2013). Non-steroidal anti-inflammatory drug use and brain tumour risk: a case-control study within the Clinical Practice Research Datalink. Cancer Causes Control. http://doi.org/10.1007/s10552-013-0279-9
View
Hicks, B. M., Murray, L. J., Powe, D. G., Hughes, C. M., & Cardwell, C. R. (2013). beta-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort. Ann Oncol. http://doi.org/10.1093/annonc/mdt381
View
Cardwell, C. R., Coleman, H. G., Murray, L. J., Entschladen, F., & Powe, D. G. (2013). Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort. Int J Epidemiol. http://doi.org/10.1093/ije/dyt196
View